Method for detecting content of maleic acid and chlorpheniramine in paracetamol and chlorpheniramine maleate preparation

Through the HPLC-PDA dual-wavelength detection method, the problem of difficulty in detecting maleic acid and chlorphenamine content in the aminophenol oxalin preparation in the prior art was solved, and the detection of high sensitivity and accuracy was achieved, simplifying the sample The quality control capability has been improved.

CN118937544APending Publication Date: 2024-11-12CHINA RESOURCES SANJIU MEDICAL & PHARMA CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411241993.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art is difficult to simultaneously detect the content of maleic acid and chlorphenamine in the aminophenol oxalin preparation, especially when maleic acid degrades, affecting the stability of chlorphenamine, resulting in difficulty in quality control.

Method used

Using HPLC-PDA dual-wavelength detection method, the use of octadecylsilane bonded silica gel filler, potassium dihydrogen phosphate solution as mobile phase, gradient elution procedure and specific wavelength detection, to achieve the Maleic acid and chlorphenamine were tested simultaneously.

Benefits of technology

The high sensitivity, accuracy and good linear detection of maleic acid and chlorphenamine content in paracetamol yellow namin particles is achieved, simplifying the sample pretreatment process and facilitating quality control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937544A_ABST
    Figure CN118937544A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of quality detection of traditional Chinese medicine preparations, and particularly relates to a method for simultaneously detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine maleate preparation. According to the liquid phase detection method capable of simultaneously detecting the maleic acid content and the chlorpheniramine content in the paracetamol and chlorpheniramine maleate particles, an HPLC-PDA dual-wavelength detection method is adopted, the specificity is high, the sensitivity is high, the accuracy is good, the linearity is good, the sample pretreatment process is simple and rapid, and the detection accuracy is high. The content of maleic acid and the content of chlorpheniramine maleate in the paracetamol and chlorpheniramine maleate granules can be effectively detected at the same time, and product quality control of the content of chlorpheniramine maleate in the paracetamol and chlorpheniramine maleate granules is facilitated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of quality detection of traditional Chinese medicine preparations, and particularly relates to a method for simultaneously detecting the contents of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation. Background Art

[0002] At present, the active ingredients of the pediatric acetaminophen granules sold on the market are chlorpheniramine maleate, acetaminophen and artificial bezoar. However, studies have found that the content of chlorpheniramine maleate in this preparation will decrease significantly when it is close to the expiration date. According to the National Drug Standard (Trial) WS-10001-(HD-0214)-2002, only the limit requirement for the labeled content of acetaminophen is 95.0%-105.0%; and the 2016 National Standard Draft for Comments (hereinafter referred to as the Draft for Comments) added the limit requirement for the labeled content of chlorpheniramine maleate to 90.0%-110.0%. In the Draft for Comments, the detection method of chlorpheniramine maleate is to separate it into maleic acid and chlorpheniramine under chromatographic conditions, but this method only converts the content of chlorpheniramine maleate into the content of chlorpheniramine, and if the content of maleic acid decreases significantly, it is not included in the calculation. However, in the microenvironment, chlorpheniramine maleate will dissociate into trace amounts of maleic acid and chlorpheniramine and maintain a balance. As maleic acid degrades, the balance will be broken, affecting the further dissociation of chlorpheniramine maleate, thereby affecting the stability of chlorpheniramine maleate.

[0003] For example, Chinese patent CN103134862A discloses a method for simultaneously detecting the content of acetaminophen and chlorpheniramine maleate, but the content of chlorpheniramine maleate in the method is only measured in chlorpheniramine, without considering the degradation of maleic acid. Another example is the method for determining the content of chlorpheniramine maleate in the children's acetaminophen yellow namin granules disclosed in Chinese patents CN102608224A and CN108051527A, but the content of chlorpheniramine maleate in the method is also only measured in chlorpheniramine, without considering the degradation of maleic acid.

[0004] Therefore, the art expects to develop a detection method that can simultaneously detect the maleic acid content and chlorpheniramine content in acetaminophen granules, which is of great significance for its comprehensive quality detection and overall quality control. Summary of the invention

[0005] To this end, the technical problem to be solved by the present invention is to provide a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation, the method having the advantages of simple sample pretreatment, high detection sensitivity and good linearity, and being able to simultaneously complete the detection of the content of maleic acid and chlorpheniramine in the paracetamol and chlorpheniramine preparation;

[0006] The second technical problem to be solved by the present invention is to provide the application of the above-mentioned liquid phase detection method for simultaneously detecting the maleic acid content and the chlorpheniramine content in the acetaminophen preparation in the field of quality control of the acetaminophen preparation.

[0007] In order to solve the above technical problems, the method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation of the present invention comprises the steps of performing HPLC dual-wavelength detection on a test solution of paracetamol and chlorpheniramine granules;

[0008] The chromatographic conditions include: using octadecylsilane bonded silica gel as a filler, using 0.01-0.1 mol / L potassium dihydrogen phosphate solution with a pH of 2.2-3.2 as a mobile phase A, using acetonitrile as a mobile phase, and performing gradient elution according to the following procedure:

[0009] 0-10min, A:B is 100%:0%;

[0010] 10-20min, A:B is 100%:0%→75%:25%;

[0011] 20-35min, A:B is 75%:25%;

[0012] 35-36min, A:B is 75%:25%→100%:0%;

[0013] 36-50min, A:B is 100%:0%.

[0014] Preferably, in the chromatographic conditions, the mobile phase A is preferably a 0.02 mol / L potassium dihydrogen phosphate solution with a pH of 2.9.

[0015] Specifically, in the method for detecting the content of maleic acid and chlorpheniramine in the acetaminophen preparation, in the HPLC dual-wavelength detection step, the detection wavelength of maleic acid is 210±2nm, and the detection wavelength of chlorpheniramine is 262±2nm.

[0016] Specifically, in the method for detecting the content of maleic acid and chlorpheniramine in the acetaminophen preparation, in the HPLC dual-wavelength detection step, the chromatographic conditions also include: column temperature 20-40°C, flow rate 0.5-1.5ml / min, and injection volume 20μl-200μl.

[0017] Specifically, in the method for detecting the content of maleic acid and chlorpheniramine in the acetaminophen preparation, in the HPLC dual-wavelength detection step, the detector is a PDA detector.

[0018] Specifically, in the method for detecting the content of maleic acid and chlorpheniramine in the paracetamol and chlorpheniramine preparation, in the HPLC dual-wavelength detection step, the chromatographic column is a C18 column;

[0019] Preferably, the chromatographic column is an ODS column.

[0020] Specifically, the method for detecting the content of maleic acid and chlorpheniramine in the acetaminophen preparation, the method for preparing the test solution comprises: taking the acetaminophen granules test sample, accurately adding a diluent, sealing and ultrasonically treating, filtering and collecting the filtrate, and obtaining.

[0021] Specifically, in the method for detecting the content of maleic acid and chlorpheniramine in the acetaminophen preparation, the diluent includes a potassium dihydrogen phosphate solution or a mixed solution of a potassium dihydrogen phosphate solution and acetonitrile;

[0022] Preferably, the concentration of the potassium dihydrogen phosphate solution is 0.01-0.1 mol / L and the pH is 2.2-3.2.

[0023] Specifically, the method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation further comprises the step of preparing a reference solution;

[0024] The reference substance includes chlorpheniramine maleate.

[0025] Specifically, the method for detecting the content of maleic acid and chlorpheniramine in a paracetamol preparation comprises paracetamol granules.

[0026] The invention also discloses application of the method for detecting the contents of maleic acid and chlorpheniramine in a paracetamol-chlorpheniramine preparation in the field of quality detection of paracetamol-chlorpheniramine preparations.

[0027] The liquid phase detection method provided by the present invention can simultaneously detect the maleic acid content and the chlorpheniramine content in the acetaminophen granules, and adopts the HPLC-PDA dual-wavelength detection method, which not only has strong specificity, high sensitivity, good accuracy, and good linearity, but also has a simple and fast sample pretreatment process, and can effectively detect the maleic acid content and the chlorpheniramine content in the acetaminophen granules at the same time, which is helpful for product quality control of the chlorpheniramine maleate content in the acetaminophen granules. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In order to make the content of the present invention more clearly understood, the present invention is further described in detail below according to specific embodiments of the present invention in conjunction with the accompanying drawings, wherein:

[0029] Figure 1 is the liquid chromatogram of the diluent in Example 2;

[0030] Figure 2 It is the liquid chromatogram of the reference substance solution in Example 2;

[0031] Figure 3It is the liquid chromatogram of the test solution in Example 2;

[0032] Figure 4 This is the standard curve of maleic acid concentration and peak area;

[0033] Figure 5 This is the standard curve of chlorpheniramine concentration and peak area. DETAILED DESCRIPTION

[0034] The embodiments of the present invention will be described in detail below in conjunction with the examples, but it will be understood by those skilled in the art that the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If no specific conditions are specified in the examples, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.

[0035] Example 1

[0036] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0037] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.90 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0038] Preparation of test solution: Accurately weigh 6.0633 g of acetaminophen granules (equivalent to 0.5 mg of chlorpheniramine maleate), place in a 50 ml volumetric flask, add 25 ml of diluent (same as mobile phase A), dissolve by ultrasonication, add diluent (same as mobile phase A) to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the test solution No. 1.

[0039] Preparation of reference solution: Accurately weigh 9.978 mg of chlorpheniramine maleate reference substance, place in a 100 ml volumetric flask, add about 50 ml of diluent (same as mobile phase A) and dissolve by ultrasonication, add diluent (same as mobile phase A) to dilute to the scale, accurately measure 1 ml and place in a 10 ml volumetric flask, add diluent (same as mobile phase A) to dilute to the scale, shake well, and filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0040] The HPLC chromatographic conditions are as follows: the chromatographic column is phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111), the detector is a PDA detector, the mobile phase A is a potassium dihydrogen phosphate solution pH 2.90, the mobile phase B is acetonitrile, gradient elution is performed according to Table 1, the injection volume is 20 μl, the column temperature is 30°C, the flow rate is 0.5 ml / min, the detection wavelength of maleic acid is 210 nm, and the detection wavelength of chlorpheniramine is 262 nm.

[0041] Table 1 Gradient elution program

[0042] Running time / min Phase A: Potassium dihydrogen phosphate solution (pH 2.9) Phase B: Acetonitrile 0 100 0 10 100 0 20 75 25 35 75 25 36 100 0 50 100 0

[0043] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, perform gradient elution according to the above Table 1, obtain the reference peak area and the test peak area, substitute them into the following formula (1) to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0044]

[0045] in,

[0046] C is the percentage content of chlorpheniramine maleate in the test sample, %;

[0047] Wr is the sample weight of the reference substance, g;

[0048] Ws is the sample weight of the test product, g;

[0049] W is the average bag weight of the test product, g;

[0050] A S is the main peak area of ​​the test solution;

[0051] A r is the main peak area of ​​the reference solution;

[0052] Vs is the dilution volume of the test solution, ml;

[0053] Vr is the dilution volume of the reference solution, ml;

[0054] F is the labeled content of the test sample, mg.

[0055] Example 2

[0056] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0057] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.90 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0058] Preparation of test solution: Accurately weigh 6.0487 g of chlorpheniramine maleate granules (equivalent to 0.5 mg of chlorpheniramine maleate), place in a 50 ml volumetric flask, add 25 ml of diluent (same as mobile phase A), ultrasonically dissolve, add diluent (same as mobile phase A) to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the test solution No. 2.

[0059] Preparation of reference solution: Accurately weigh 9.933 mg of chlorpheniramine maleate reference substance, place in a 100 ml volumetric flask, add about 50 ml of diluent (same as mobile phase A) and ultrasonically dissolve, add diluent (same as mobile phase A) to dilute to the scale, accurately measure 1 ml and place in a 10 ml volumetric flask, add diluent (same as mobile phase A) to dilute to the scale, shake well, and filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0060] HPLC chromatographic conditions are as follows: phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111) was used as the chromatographic column; mobile phase A was potassium dihydrogen phosphate solution, pH 2.90; mobile phase B was acetonitrile; gradient elution was performed according to the procedure shown in Table 1 in Example 1; the detector was a PDA detector; the injection volume was 20 μl; the column temperature was 30° C.; the flow rate was 0.7 ml / min; the detection wavelength for maleic acid was 210 nm; and the detection wavelength for chlorpheniramine was 262 nm.

[0061] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, obtain the peak area of ​​the reference solution and the peak area of ​​the test solution, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0062] In this embodiment, under the above chromatographic conditions, the liquid chromatogram of the diluent is shown in the attached Figure 1 (See the chromatograms of duplicate samples for Figure 1 a and b), the liquid chromatogram of the reference solution is attached Figure 2 (The chromatograms of maleic acid and chlorpheniramine reference substances are shown in Figure 2 a and b), the liquid chromatogram of the test solution is attached Figure 3 (a) and (b).

[0063] It can be seen that the dual wavelength used in this embodiment to simultaneously detect the maleic acid content and the chlorpheniramine content in the particles is not affected by the excipients.

[0064] Example 3

[0065] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0066] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.90 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0067] Preparation of test solution: Accurately weigh 6.0215 g of acetaminophen granules (equivalent to 0.5 mg of chlorpheniramine maleate) and place in a 50 ml volumetric flask. Add 25 ml of diluent and dissolve by ultrasonic. Add diluent to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the test solution No. 3.

[0068] Preparation of reference solution: Accurately weigh 10.018 mg of chlorpheniramine maleate reference substance, place in a 100 ml volumetric flask, add about 50 ml of diluent and dissolve by ultrasonic, add diluent to dilute to the scale, accurately measure 1 ml and place in a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, and filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0069] The HPLC chromatographic conditions are as follows: the chromatographic column is phenomenex-C18, 250μ4.6mm, 4μm (LC110, LC111), the mobile phase A is potassium dihydrogen phosphate solution pH2.90, the mobile phase B is acetonitrile, the detector is a PDA detector, the injection volume is 200μl, the column temperature is 40°C, the flow rate is 1.5ml / min, the detection wavelength of maleic acid is 210nm, and the detection wavelength of chlorpheniramine is 262nm.

[0070] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, obtain the peak area of ​​the reference solution and the peak area of ​​the test solution, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0071] Example 4

[0072] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0073] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.90 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0074] Preparation of test solution: Accurately weigh 6.0012 g of acetaminophen granules (equivalent to 0.5 mg of chlorpheniramine maleate) and place in a 50 ml volumetric flask. Add 25 ml of diluent and dissolve by ultrasonic. Add diluent to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the No. 4 test solution.

[0075] Preparation of reference solution: Accurately weigh 10.002 mg of chlorpheniramine maleate reference substance, place in a 100 ml volumetric flask, add about 50 ml of diluent and dissolve by ultrasonic, add diluent to dilute to the scale, accurately measure 1 ml and place in a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0076] HPLC chromatographic conditions are: phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111) was used as the chromatographic column; mobile phase A was potassium dihydrogen phosphate solution, pH 2.90; mobile phase B was acetonitrile; gradient elution was performed according to the procedure shown in Table 1 in Example 1; the detector was a PDA detector; the injection volume was 200 μl; the column temperature was 20°C; the flow rate was 0.5 ml / min; the detection wavelength for maleic acid was 210 nm; and the detection wavelength for chlorpheniramine was 262 nm.

[0077] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, obtain the peak area of ​​the reference solution and the peak area of ​​the test solution, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0078] Example 5

[0079] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0080] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.90 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0081] Preparation of test solution: Accurately weigh 6.0024 g of acetaminophen granules (equivalent to approximately 0.5 mg of chlorpheniramine maleate) and place in a 50 ml volumetric flask. Add 25 ml of diluent and dissolve by ultrasonication. Add diluent to make up to volume, shake well, and filter through a 0.45 μm water filter membrane. The filtrate is the No. 5 test solution.

[0082] Preparation of reference solution: Accurately weigh 10.011 mg of chlorpheniramine maleate reference substance, place it in a 100 ml volumetric flask, add about 50 ml of diluent and dissolve it by ultrasonic, add diluent to dilute to the scale, accurately measure 1 ml and place it in a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, and filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0083] HPLC chromatographic conditions are as follows: chromatographic column using phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111), mobile phase A: potassium dihydrogen phosphate solution pH 2.90, mobile phase B: acetonitrile, gradient elution is performed according to the program shown in Table 1 in Example 1, the detector is a PDA detector, the injection volume is 200 μl, the column temperature is 30°C, the flow rate is 1.0 ml / min, the detection wavelength for maleic acid is 210 nm, and the detection wavelength for chlorpheniramine is 262 nm.

[0084] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, obtain the peak area of ​​the reference solution and the peak area of ​​the test solution, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0085] Example 6

[0086] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0087] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.90 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0088] Preparation of test solution: Accurately weigh 6.0031 g of acetaminophen granules (equivalent to 0.5 mg of chlorpheniramine maleate) and place in a 50 ml volumetric flask. Add 25 ml of diluent and dissolve by ultrasonic. Add diluent to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the No. 6 test solution.

[0089] Preparation of reference solution: Accurately weigh 10.005 mg of chlorpheniramine maleate reference substance, place it in a 100 ml volumetric flask, add about 50 ml of diluent and dissolve it by ultrasonic, add diluent to dilute to the scale, accurately measure 1 ml and place it in a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, and filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0090] HPLC chromatographic conditions are as follows: chromatographic column using phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111), mobile phase A: potassium dihydrogen phosphate solution pH 2.90, mobile phase B: acetonitrile, gradient elution is performed according to the program shown in Table 1 in Example 1, the detector is a PDA detector, the injection volume is 200 μl, the column temperature is 20°C, the flow rate is 1.5 ml / min, the detection wavelength for maleic acid is 210 nm, and the detection wavelength for chlorpheniramine is 262 nm.

[0091] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, obtain the peak area of ​​the reference solution and the peak area of ​​the test solution, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0092] Example 7

[0093] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0094] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.90 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0095] Preparation of test solution: Accurately weigh 6.0010 g of acetaminophen granules (equivalent to 0.5 mg of chlorpheniramine maleate), place in a 50 ml volumetric flask, add 25 ml of diluent and ultrasonically dissolve, add diluent to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the No. 7 test solution.

[0096] Preparation of reference solution: Accurately weigh 10.008 mg of chlorpheniramine maleate reference substance, place it in a 100 ml volumetric flask, add about 50 ml of diluent and dissolve it by ultrasonic, add diluent to dilute to the scale, accurately measure 1 ml and place it in a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, and filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0097] HPLC chromatographic conditions are: chromatographic column using phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111), mobile phase A: potassium dihydrogen phosphate solution pH 2.90, mobile phase B: acetonitrile, gradient elution is performed according to the program shown in Table 1 in Example 1, the detector is a PDA detector, the injection volume is 200 μl, the column temperature is 40°C, the flow rate is 0.5 ml / min, the detection wavelength of maleic acid is 210 nm, and the detection wavelength of chlorpheniramine is 262 nm.

[0098] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, obtain the peak area of ​​the reference solution and the peak area of ​​the test solution, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0099] Example 8

[0100] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0101] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 2.20 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0102] Preparation of test solution: Accurately weigh 6.0125 g of acetaminophen granules (equivalent to 0.5 mg of chlorpheniramine maleate) and place in a 50 ml volumetric flask. Add 25 ml of diluent and dissolve by ultrasonic. Add diluent to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the No. 9 test solution.

[0103] Preparation of reference solution: Accurately weigh 10.002 mg of chlorpheniramine maleate reference substance, place in a 100 ml volumetric flask, add about 50 ml of diluent and dissolve by ultrasonic, add diluent to dilute to the scale, accurately measure 1 ml and place in a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0104] HPLC chromatographic conditions are as follows: chromatographic column using phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111), mobile phase A: potassium dihydrogen phosphate solution pH 2.20, mobile phase B: acetonitrile, gradient elution is performed according to the program shown in Table 1 in Example 1, the detector is a PDA detector, the injection volume is 20 μl, the column temperature is 30°C, the flow rate is 0.7 ml / min, the detection wavelength for maleic acid is 210 nm, and the detection wavelength for chlorpheniramine is 262 nm.

[0105] Accurately measure 20 μl of the reference solution and the test solution, inject them into the liquid chromatograph for detection, obtain the peak area of ​​the reference solution and the peak area of ​​the test solution, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0106] Example 9

[0107] This embodiment provides a liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules.

[0108] Preparation of mobile phase A (0.020 mol / L potassium dihydrogen phosphate solution): weigh 2.72 g of potassium dihydrogen phosphate, dilute to 1000 ml with water, adjust the pH to 3.20 with phosphoric acid, and filter through a 0.45 μm water filter membrane.

[0109] Preparation of test solution: Accurately weigh 6.0047 g of acetaminophen granules (equivalent to 0.5 mg of chlorpheniramine maleate) and place in a 50 ml volumetric flask. Add 25 ml of diluent and dissolve by ultrasonic. Add diluent to make up to volume, shake well, filter through a 0.45 μm water filter membrane, and the filtrate is the No. 8 test solution.

[0110] Preparation of reference solution: Accurately weigh 9.989 mg of chlorpheniramine maleate reference substance, place in a 100 ml volumetric flask, add about 50 ml of diluent and dissolve by ultrasonic, add diluent to dilute to the scale, accurately measure 1 ml and place in a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, and filter through a 0.45 μm water filter membrane to obtain the reference solution.

[0111] The HPLC chromatographic conditions are as follows: the chromatographic column is phenomenex-C18, 250×4.6 mm, 4 μm (LC110, LC111), the mobile phase A is potassium dihydrogen phosphate solution pH 3.20, the mobile phase B is acetonitrile, the gradient elution is performed according to Table 1, the detector is a PDA detector, the injection volume is 20 μl, the column temperature is 30°C, the flow rate is 0.7 ml / min, the detection wavelength of maleic acid is 210 nm, and the detection wavelength of chlorpheniramine is 262 nm.

[0112] Accurately measure 20 μl of the reference solution and the test solution, inject them into a liquid chromatograph for detection, perform gradient elution according to the procedure shown in Table 1 in Example 1, obtain the reference peak area and the test peak area, substitute them into the formula to calculate the labeled content of maleic acid and the labeled content of chlorpheniramine.

[0113] Experimental example

[0114] The following is a methodological investigation of the liquid phase detection method for simultaneously detecting the maleic acid content and the chlorpheniramine content in the acetaminophen granules provided by the present invention through experiments.

[0115] 1. Repeatability test

[0116] The same batch of acetaminophen granules was taken as samples, and the test solution was prepared in the above manner. Multiple measurements were performed using the detection method provided in Example 2, and the calculated repeatability results are shown in Table 2 below.

[0117] Table 2 Repeatability test results

[0118] Number of measurements 1 2 3 4 5 6 average RSD(%) Maleic acid content (%) 95.5 96.4 98.7 96.1 97.1 98.5 97.1 1.4 Chlorpheniramine labeled content (%) 98.0 99.3 99.8 98.8 99.3 98.5 99.0 0.7

[0119] The results show that the liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in the acetaminophen granules provided by the present invention has good repeatability.

[0120] 2. Precision inspection

[0121] The reference solution was taken and the detection method provided in Example 2 was used for 6 consecutive injections, with 20 μl injected each time. The peak area of ​​each injection was measured. The results are shown in Table 3 below.

[0122] Table 3 Precision inspection results

[0123]

[0124] The results show that the liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules provided by the present invention has good precision.

[0125] 3. Intermediate precision inspection

[0126] Two analysts used the detection method provided in Example 2 to determine the maleic acid content and chlorpheniramine content in the same batch of acetaminophen granules. Each analyst measured twice and took the average value. The results are shown in Table 4 below.

[0127] Table 4 Intermediate precision inspection results

[0128]

[0129] The results show that the liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules provided by the present invention has good intermediate precision.

[0130] 4. Recovery rate (accuracy) investigation

[0131] This experimental example adopts the spike recovery method to examine the recovery rate of the detection method provided in Example 2. The results are shown in Table 5 below.

[0132] Table 5 Recovery rate investigation results

[0133]

[0134]

[0135] 5. Linear range investigation

[0136] This experimental example examined the linear range based on the detection method provided in Example 2, and the results are shown in Table 6 below.

[0137] Table 6 Linear range investigation results

[0138]

[0139] The results show that the liquid phase detection method provided by the present invention for simultaneously detecting the content of maleic acid and the content of chlorpheniramine in acetaminophen granules has good linearity.

[0140] The linear range of maleic acid was 1.485μg / ml-4.455μg / ml, the fitting regression equation was y=204480.7591X+18552.6000, the correlation coefficient R=0.9997, and the standard curve was attached. Figure 4 The linear range of chlorpheniramine is 3.516μg / ml-10.548μg / ml, the fitting regression equation is y=31648.8121X-2216.0000, the correlation coefficient R=0.9998, and the standard curve is attached. Figure 5 .

[0141] 6. Durability inspection

[0142] This experimental example conducted a durability test based on the detection method provided in the aforementioned Examples 1-9, and the results are shown in Table 7 below.

[0143] Table 7 Durability test results

[0144]

[0145]

[0146] The results show that the liquid phase detection method for simultaneously detecting the content of maleic acid and chlorpheniramine in acetaminophen granules provided by the present invention has good durability.

[0147] In summary, the liquid phase detection method for simultaneously detecting the maleic acid content and the chlorpheniramine content in the acetaminophen granules of the present invention adopts the HPLC-PDA dual-wavelength detection method, which not only has strong specificity, high sensitivity, good accuracy and good linearity, but also can effectively detect the maleic acid content and the chlorpheniramine content in the acetaminophen granules at the same time.

[0148] Obviously, the above embodiments are merely examples for the purpose of clear explanation, and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived therefrom are still within the scope of protection of the invention.

Claims

1. A method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation, characterized in that: The method comprises the steps of performing HPLC dual-wavelength detection on a test solution of the aminophenoxyphenol yellow namin granules; The chromatographic conditions include: using octadecylsilane bonded silica gel as a filler, using 0.01-0.1 mol / L potassium dihydrogen phosphate solution with a pH of 2.2-3.2 as a mobile phase A, using acetonitrile as a mobile phase, and performing gradient elution according to the following procedure: 0-10min, A:B is 100%:0%; 10-20min, A:B is 100%:0%→75%:25%; 20-35min, A:B is 75%:25%; 35-36min, A:B is 75%:25%→100%:0%; 36-50min, A:B is 100%:0%.

2. The method for detecting the content of maleic acid and chlorpheniramine in the paracetamol and chlorpheniramine preparation according to claim 1, wherein: In the HPLC dual-wavelength detection step, the detection wavelength of maleic acid is 210±2 nm, and the detection wavelength of chlorpheniramine is 262±2 nm.

3. The method for detecting the content of maleic acid and chlorpheniramine in the paracetamol and chlorpheniramine preparation according to claim 1 or 2, characterized in that: In the HPLC dual-wavelength detection step, the chromatographic conditions also include: column temperature 20-40°C, flow rate 0.5-1.5 ml / min, and injection volume 20 μl-200 μl.

4. The method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation according to any one of claims 1 to 3, characterized in that: In the HPLC dual-wavelength detection step, the detector is a PDA detector.

5. The method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation according to any one of claims 1 to 4, characterized in that: In the HPLC dual-wavelength detection step, the chromatographic column is a C18 column; Preferably, the chromatographic column is an ODS column.

6. The method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation according to any one of claims 1 to 5, characterized in that: The preparation method of the test solution comprises: taking the acetaminophen granules test sample, accurately adding a diluent, sealing, subjecting to ultrasonic treatment, filtering and collecting the filtrate, and obtaining the solution.

7. The method for detecting the content of maleic acid and chlorpheniramine in the paracetamol and chlorpheniramine preparation according to claim 6, characterized in that: The diluent includes a potassium dihydrogen phosphate solution or a mixed solution of a potassium dihydrogen phosphate solution and acetonitrile; Preferably, the concentration of the potassium dihydrogen phosphate solution is 0.01-0.1 mol / L and the pH is 2.2-3.

2.

8. The method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation according to any one of claims 1 to 7, characterized in that: The method further comprises the steps of preparing a reference solution; The reference substance includes chlorpheniramine maleate.

9. The method for detecting the content of maleic acid and chlorpheniramine in a paracetamol and chlorpheniramine preparation according to any one of claims 1 to 8, characterized in that: The acetaminophen preparation comprises acetaminophen granules.

10. Application of the method for detecting the content of maleic acid and chlorpheniramine in a paracetamol-chlorpheniramine preparation according to any one of claims 1 to 9 in the field of quality inspection of paracetamol-chlorpheniramine preparations.

Citation Information

Patent Citations

  • Method for measuring content of chlorphenamine maleate in pediatric paracetamol, artificial cow-bezoar and chlorphenamine maleate granules

    CN102608224A

  • Quality testing method for pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate granules

    CN103134862A

  • Quality control method of pediatric paracetamol, artificial bezoar and chlorphenamine maleate granules

    CN108051527A